Bilayer Tablets of Antihypertensive Drugs: An Overview
Keywords:
Bilayer Tablets, Antihypertensive Drugs, Overview, Immediate release, BioavailabilityAbstract
Bilayer tablets are a type of modified-release dosage form designed to deliver two active pharmaceutical ingredients (APIs) simultaneously or sequentially from different layers of the tablet. This formulation technique is particularly useful when combining multiple antihypertensive agents in a single dosage form. By using bilayer tablets, two different mechanisms of action or two complementary drugs can be delivered in a controlled and systematic manner, improving both patient compliance and therapeutic efficacy. One layer can be designed for immediate release (IR), providing a rapid onset of action, while the second layer can be designed for controlled or sustained release (SR), maintaining therapeutic levels over an extended period. This allows for the reduction of dose frequency, leading to better patient adherence to the treatment regimen. Antihypertensive drugs often work more effectively when used in combination, targeting different mechanisms involved in hypertension. Bilayer tablets offer the advantage of combining two complementary antihypertensive drugs in one formulation, ensuring their simultaneous release. By using a combination of drugs with different release profiles, bilayer tablets can reduce the incidence of side effects. For instance, the immediate release layer can handle acute symptoms, while the sustained release layer can control long-term blood pressure regulation. Certain drugs in combination can have enhanced bioavailability when administered in a bilayer tablet format, potentially leading to a more consistent therapeutic effect. Instead of taking multiple tablets or capsules for combination therapy, patients can take one bilayer tablet, improving convenience and compliance. Bilayer tablets represent an innovative approach to combination therapy in hypertension management. By providing controlled, sustained, and immediate release of two antihypertensive drugs, these tablets offer a convenient, effective, and patient-friendly solution for managing high blood pressure. The use of bilayer tablets not only improves therapeutic outcomes but also enhances patient compliance by reducing the pill burden and simplifying the dosing schedule.
Downloads
References
Ravali, M., Prathyusha, A., & Rao, V. U. M. (2015) ‘An overview on Bilayer Tablet’. International Journal of Innovative Pharmaceutical Sciences and Research, vol. 3, no. 5, pp. 451-469.
Yie,W.C.(1992)Novel drug delivery systems,Marcel Dekker Inc,2nded.
Chien, Y. W. (1992) Novel drug delivery systems. Marcel Dekker Inc, 2nd New York, 139-140.
Aulton, M E. (2002) Pharmaceutics, The Science of dosage form design (Bilayer Tablets), 2nd , Churchill living stone, pp. 414-418.Lieberman, H. A., Lakman, L., Schwartz, J. B. Pharmaceutical Dosage forms: tablets, volume 3, 2nd edition.
Aggarwal, S., Syan, N., & Mathur, P. (2013) ‘Bi-layer tablet technology— opening new ways in drug delivery systems: an over view’. International journal of research in pharmaceutical and biomedical sciences, vol.4, pp. 2229-3701.
Ashok, P. H., & Kumar, T. A. (2012). ‘A Novel Approach of Bi-layer Tablet Technology-A review’. International research journal of pharmacy,vol. 3, no. 5,Pp.44-49.
Rishikesh, G., Paul, T. R., Mohiuddin, A. A. (2014) ‘Bilayered Tablet Technology: An Overview’. World Journal of Pharmaceutical Research, vol. 3, no. 4, pp. 150-163.
Gopinath, C., Bindu, V. H., & Nischala, M. (2013) ‘An overview on bilayered tablettechnology’.Journalofglobaltrendsinpharmaceuticalsciences, vol.4,no. 2, pp. 1077-1085.
Barthwal, P., Ganarajan, G., Kothiyal, P. (2013). ‘Bilayer a review’, International Journal of chemical and pharmaceutical sciences, vol. 2, no. 4, pp. 1788-1797.
Jha, M. K., Rahman, M. H., & Rahman, M. M. (2011) ‘Biphasic oral solid drug delivery system: A review’. International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 5, pp. 1108.
Verma, R., Devre, K., Gangrade, T. (2014) ‘Bi-layer tablets for various drugs: A review’. Scholars Academic Journal of Pharmacy, vol. 3, no. 3, pp. 271-279.
http://www.port/technology.com
Verma, R. K., & Garg, S. (2001) ‘Drug delivery technologies and future directions’. Pharmaceutical Technology, vol. 25, no. 2, pp. 1-14.
Kaur, P., Dhiram, S., & Arora, S. (2013) ‘Floating Bilayer Tablet Technology: A Review’. International Journal Pharmaceutical Sciences Review Research,vol. 19, no. 1, pp. 112-122.
Arun,D.,VenuGopal,N.,Shekar,L.,Ramarav,B.,Karunakar,K.,&Surendra,
Y. (2012) ‘A review of novel approach in bilayer tablet technology’. International Journal of Pharmaceutical, Biological and Chemical Sciences, vol.1, no.1, pp.1- 8.
Kale,S.S.,Saste,V.S.,Ughade,P.L.,&Baviskar,D.T.(2011)‘Bilayer tablet’. International Journal of Pharmaceutical Sciences Review and Research, vol. 9, no. 1, pp. 25-30.
Ravula, A. N., & Goud, B. A. (2011) ‘Recent advances in oral pulsatile drug delivery’. Journal of Advanced Pharmaceutical Sciences, vol. 1, no. 1, pp. 57-62.
Bingi,M.,Gudas,G.,Debnath,S.,Sreekanth,C.B.V.,Raguveer,P.,&Srikanth,
T. (2011) ‘Design and evaluation of buccoadhesive bi-layer tablet of paroxetine hydrochloride’.International Journal of Pharma Professional's Research,vol.2, no. 1, pp. 195-197.
Natarajan, R., Vaishnani, R., & Rajendran, N. N. (2011) ‘Formulation and evaluation of immediate release tablets of paroxetine HCl using different super disintegrants’.International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 2, no. 3, pp. 1095-1099.
Timmins, P., Dennis, A. B., & Vyas, K. A. (2002) U.S. Patent No. 6,475,521. Washington, DC: U.S. Patent and Trademark Office.
Patel, M., Sockan, G. N., & Tamizh, M. (2010) ‘Challenges in the formulation of bilayered tablets: A review’. International Journal of Pharmaceutical Research & Development, vol. 2, no. 10, pp. 005.
Jan Vogeleer, Bialyer Tablet- Why special Technique required. The Courtoy- R292F Tablet Press designed for Quality Bilayer Tablet, Niro Pharma System.
Abshagen, U., & Spörl-Radun, S. (1981) ‘First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man’. European journal of clinical pharmacology, vol. 19, no. 6, pp. 423-429.
Namrata,M.,Sirisha,V.N.L.,Sruthi,B.,Harika,I.B.,Kirankumar,P.,Rao,Y.
K.K.,&Rao,O. U.(2013) ‘A Review on Bi-layer Tablets’. International Journal of Pharmaceutical and Psychopharmacological Research, vol. 1, no. 2, pp. 240- 246.
Joseph, R. R. (1996) In; Banker, GS and Rhodes, CT, Eds., Modern Pharmaceutics, 3rd Edn., Vol. 72.New York, Marcel Dekker Inc.369.
Li, S. P., Karth, M. G., Feld, K. M., Di Paolo, L. C., Pendharkar, C. M., & Williams,R.O.(1995)‘Evaluation of bilayer tablet machines—case study’. Drug development and industrial pharmacy, vol. 21, no. 5, pp. 571-590.
Patel, J. S. (2013) ‘A review on bilayer tablets’. Journal of drug discovery and therapeutics, vol. 1, no. 03, pp. 40-48.
Nilawar, P. S., Wankhade, V. P., & Badnag, D. B. (2013) ‘An emerging trend on bilayer tablets’.International journal of pharmacy and pharmaceutical science research, vol. 3, no. 1, pp. 15-21..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
